CRLF2 and acute lymphoblastic leukemia: Finally, we detected fusion transcripts in 78% of BCP-ALL models (25/33), many of which contain ETV6 (27%; 88% of these partner with RUNX1), PAX5 (18%), and CRLF2 (6%) (Table S5).